Physician profile

David Joseph Sosnowik

Gastroenterology (Internal Medicine) · Forest Hills, NY

NPI 1053378075

$3,368.44

in general payments reported to CMS, 2019-2025

33 companies · $184 in 2025

The $184 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).

See the full distribution for Gastroenterology (Internal Medicine)

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$1,274.88

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Amarin Pharma, INC. $363.32 2019-2022
Abbvie INC. $341.71 2019-2024 Skyrizi, Rinvoq
Qol Medical, LLC $318.24 2020-2024 Sucraid, Sucraid
Glaxosmithkline, LLC. $270.97 2021-2023 Shingrix, Arexvy
Janssen Biotech, INC. $240.02 2022-2025 Tremfya, Simponi, Simponi Aria
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $197.79 2020-2024 Xifaxan
Takeda Pharmaceuticals U.S.A., INC. $167.23 2020-2025 Entyvio, Vpriv
Novo Nordisk INC $155.02 2021-2024 Ozempic, Rybelsus
E.R. Squibb & Sons, L.L.C. $150.00 2023
Merck Sharp & Dohme LLC $104.86 2020-2024 Gardasil 9, Gardasil
Braintree Laboratories, INC. $104.72 2019-2024 Sutab, Suflave
Celgene Corporation $68.20 2023-2024 Zeposia
Astrazeneca Pharmaceuticals LP $67.25 2024 Airsupra, Farxiga
Daiichi Sankyo INC. $64.10 2022-2024 Injectafer
Phathom Pharmaceuticals, INC. $63.80 2023-2025 Voquezna
Show all 33 companies
CompanyGeneral paymentsYearsTop products
Redhill Biopharma INC. $62.64 2021-2022
Shire North American Group INC $60.85 2019
Ferring Pharmaceuticals INC. $60.12 2020-2021
Intercept Pharmaceuticals, INC. $59.15 2019-2021
Pfizer INC. $56.82 2023-2024
Alfasigma USA, INC. $53.56 2020-2021
Exact Sciences Corporation $47.93 2023-2024 Cologuard Collection Kit
Lilly USA, LLC $43.40 2023 Mounjaro
Intra-Sana Laboratories $39.26 2021-2022
Celltrion USA INC. $35.43 2024-2025 Vegzelma
Glycomark, INC. $31.04 2019
Genzyme Corporation $30.70 2024
Ironwood Pharmaceuticals, INC $21.80 2020
Alnylam Pharmaceuticals INC. $21.11 2019
Janssen Pharmaceuticals, INC $19.04 2020
Shield Therapeutics INC $16.71 2024
Allergan, INC. $16.08 2019
Medline Industries LP $15.57 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

David Joseph Sosnowik

$3,368.44

in general payments reported 2019-2025

Years
2019-2025
Top company
Amarin Pharma, INC.
Context
The $184 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).

https://glasscript.com/doctor/2535/david-joseph-sosnowik

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.